Ocular Therapeutix Inc. (OCUL)
NASDAQ: OCUL
· Real-Time Price · USD
12.60
-0.05 (-0.40%)
At close: Aug 15, 2025, 3:59 PM
12.80
1.59%
After-hours: Aug 15, 2025, 07:10 PM EDT
Ocular Therapeutix Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -216.75M | -192.71M | -193.51M | -174.34M | -138.36M | -115.27M | -80.74M | -67.06M | -90.73M | -88.81M | -71.04M | -59.35M | -32.5M | -22.22M | -6.55M | -88.31M | -102.92M | -131M |
Depreciation & Amortization | 3.92M | 3.85M | 3.79M | 3.79M | 3.72M | 3.42M | 2.98M | 2.52M | 2.13M | 2.04M | 2.11M | 2.19M | 2.27M | 2.33M | 2.42M | 2.52M | 2.59M | 2.69M |
Stock-Based Compensation | 33.97M | 35.59M | 33.11M | 30.24M | 28.11M | 21.23M | 17.82M | 17.73M | 17.46M | 17.33M | 16.96M | 16.57M | 16.09M | 16.1M | 14.98M | 13.24M | 11.42M | 8.95M |
Other Working Capital | 473K | 9.68M | -2.97M | -11.07M | -7.12M | -13.44M | -2.81M | 2.7M | 2.36M | 1.21M | 2.88M | 2.16M | 3.63M | 3.02M | 4.24M | 15.02M | 14M | 13.95M |
Other Non-Cash Items | 3.31M | 5.04M | 40.92M | 62.41M | 70.94M | 68.6M | 32.56M | 7.11M | 7.39M | 4.57M | -8.99M | -19.66M | -20.86M | -18.15M | -11.24M | 4.58M | 4.54M | 4.5M |
Deferred Income Tax | n/a | n/a | n/a | -8.23M | -29.14M | -30.27M | -30.27M | -22.04M | -1.13M | n/a | n/a | n/a | -23.84M | -37.23M | -62.25M | 7.3M | 27.37M | 57.77M |
Change in Working Capital | 5.18M | 8.31M | -10.23M | -17.64M | -10.21M | -17.92M | -7.41M | -2.99M | -5.3M | 3.9M | 1.35M | 2.45M | 1.23M | -7.63M | -2.9M | 4.04M | -316K | 5.04M |
Operating Cash Flow | -175.9M | -145.46M | -134.68M | -112.52M | -83.69M | -78.96M | -65.05M | -64.74M | -70.17M | -60.98M | -59.6M | -57.8M | -57.61M | -66.79M | -65.55M | -56.64M | -57.32M | -52.06M |
Capital Expenditures | -3.47M | -2.97M | -1.29M | -1.54M | -1.72M | -2.96M | -6.09M | -7.78M | -8.31M | -6.82M | -3.71M | -2.2M | -1.68M | -1.31M | -1.19M | -816K | -754K | -750K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 130K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -3.34M | -2.97M | -1.29M | -1.54M | -1.72M | -2.96M | -6.09M | -7.78M | -8.31M | -6.82M | -3.71M | -2.2M | -1.68M | -1.31M | -1.19M | -816K | -754K | -750K |
Debt Repayment | 316.35M | 316.35M | 316.35M | n/a | -26.13M | -26.13M | -26.13M | -26.13M | n/a | n/a | n/a | n/a | n/a | 1.64M | -445K | -445K | -445K | -2.08M |
Common Stock Repurchased | 1.21M | 492K | 492K | 492K | n/a | n/a | n/a | 940K | 940K | 940K | 940K | n/a | n/a | n/a | -275K | -275K | -275K | -275K |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -300.41M | -301.28M | -300.6M | 11.69M | 89.98M | 88.61M | 83.81M | 83.83M | 1.73M | 1.4M | 1.45M | 1.39M | 1.69M | 2.23M | 2.1M | 3.65M | 3.19M | 2.88M |
Financial Cash Flow | 110.68M | 15.07M | 332.11M | 430.58M | 483.52M | 490.97M | 169.83M | 67.3M | 10.55M | 1.4M | 1.45M | 1.66M | 1.97M | 4.14M | 2.85M | 166.1M | 165.64M | 214.03M |
Net Cash Flow | -66.94M | -131.74M | 197.76M | 318.28M | 393.08M | 404.01M | 93.66M | -10.4M | -67.93M | -66.39M | -61.86M | -58.33M | -57.32M | -63.96M | -63.89M | 108.64M | 107.57M | 161.23M |
Free Cash Flow | -179.37M | -148.43M | -135.97M | -114.06M | -85.41M | -81.93M | -71.14M | -72.52M | -78.49M | -67.79M | -63.32M | -59.99M | -59.29M | -68.1M | -66.74M | -57.46M | -58.07M | -52.81M |